Skip to main content
Premium Trial:

Request an Annual Quote

Bruker BioSciences Closes $135M Acquisition of Bruker Optics

NEW YORK (GenomeWeb News) - Bruker BioSciences said today that it closed its acquisition of molecular spectroscopy company Bruker Optics on July 1.
 
The $135 million purchase price was paid approximately 59 percent in cash and 41 percent in Bruker BioSciences stock. The company said that it issued around 11.4 million new shares for the stock component of the purchase.
 
The number of shares was determined by dividing the value of the stock consideration, $55.8 million, by $4.91, the trailing average of Bruker closing prices per share for the period of ten consecutive trading days ending three days prior to the closing date.
 
Bruker BioSciences announced its plan to acquire Bruker Optics in April.

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.